Nu-Med Plus, Inc. (NUMD)
OTCMKTS · Delayed Price · Currency is USD
0.0315
0.00 (0.00%)
Sep 1, 2025, 8:00 PM EDT
Nu-Med Plus Market Cap
Nu-Med Plus has a market cap or net worth of $2.63 million as of September 3, 2025. Its market cap has decreased by -26.35% in one year.
Market Cap
2.63M
Enterprise Value
2.73M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since September 25, 2014, Nu-Med Plus's market cap has decreased from 24.57M to 2.63M, a decrease of -89.29%. That is a compound annual growth rate of -18.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 2.63M | 105.08% |
| Dec 31, 2024 | 1.28M | -62.05% |
| Dec 28, 2023 | 3.38M | 151.78% |
| Dec 30, 2022 | 1.34M | -51.67% |
| Dec 31, 2021 | 2.78M | -93.86% |
| Dec 29, 2020 | 45.21M | 141.98% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 832.17M |
| Elite Pharmaceuticals | 734.61M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 655.63M |
| Northwest Biotherapeutics | 448.50M |
| CytoDyn | 376.00M |
| American Oncology Network | 343.87M |